BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 29989169)

  • 1. Real-time optical manipulation of cardiac conduction in intact hearts.
    Scardigli M; Müllenbroich C; Margoni E; Cannazzaro S; Crocini C; Ferrantini C; Coppini R; Yan P; Loew LM; Campione M; Bocchi L; Giulietti D; Cerbai E; Poggesi C; Bub G; Pavone FS; Sacconi L
    J Physiol; 2018 Sep; 596(17):3841-3858. PubMed ID: 29989169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Software Architecture to Mimic a Ventricular Tachycardia in Intact Murine Hearts by Means of an All-Optical Platform.
    Giardini F; Biasci V; Scardigli M; Pavone FS; Bub G; Sacconi L
    Methods Protoc; 2019 Jan; 2(1):. PubMed ID: 31164591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optogenetics design of mechanistically-based stimulation patterns for cardiac defibrillation.
    Crocini C; Ferrantini C; Coppini R; Scardigli M; Yan P; Loew LM; Smith G; Cerbai E; Poggesi C; Pavone FS; Sacconi L
    Sci Rep; 2016 Oct; 6():35628. PubMed ID: 27748433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optical mapping system with real-time control capability.
    Iravanian S; Christini DJ
    Am J Physiol Heart Circ Physiol; 2007 Oct; 293(4):H2605-11. PubMed ID: 17644571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optogenetic manipulation of anatomical re-entry by light-guided generation of a reversible local conduction block.
    Watanabe M; Feola I; Majumder R; Jangsangthong W; Teplenin AS; Ypey DL; Schalij MJ; Zeppenfeld K; de Vries AA; Pijnappels DA
    Cardiovasc Res; 2017 Mar; 113(3):354-366. PubMed ID: 28395022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Termination of re-entrant atrial tachycardia via optogenetic stimulation with optimized spatial targeting: insights from computational models.
    Boyle PM; Murphy MJ; Karathanos TV; Zahid S; Blake RC; Trayanova NA
    J Physiol; 2018 Jan; 596(2):181-196. PubMed ID: 29193078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optogenetics-enabled dynamic modulation of action potential duration in atrial tissue: feasibility of a novel therapeutic approach.
    Karathanos TV; Boyle PM; Trayanova NA
    Europace; 2014 Nov; 16 Suppl 4(Suppl 4):iv69-iv76. PubMed ID: 25362173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optical mapping and optogenetics in cardiac electrophysiology research and therapy: a state-of-the-art review.
    Baines O; Sha R; Kalla M; Holmes AP; Efimov IR; Pavlovic D; O'Shea C
    Europace; 2024 Feb; 26(2):. PubMed ID: 38227822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Light-induced termination of spiral wave arrhythmias by optogenetic engineering of atrial cardiomyocytes.
    Bingen BO; Engels MC; Schalij MJ; Jangsangthong W; Neshati Z; Feola I; Ypey DL; Askar SF; Panfilov AV; Pijnappels DA; de Vries AA
    Cardiovasc Res; 2014 Oct; 104(1):194-205. PubMed ID: 25082848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What is cardiac resynchronization therapy?
    Barold SS
    Am J Med; 2001 Aug; 111(3):224-32. PubMed ID: 11530034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of fiber orientation on propagation: electrical mapping of genetically altered mouse hearts.
    Punske BB; Taccardi B; Steadman B; Ershler PR; England A; Valencik ML; McDonald JA; Litwin SE
    J Electrocardiol; 2005 Oct; 38(4 Suppl):40-4. PubMed ID: 16226072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accelerometer-based atrioventricular synchronous pacing with a ventricular leadless pacemaker: Results from the Micra atrioventricular feasibility studies.
    Chinitz L; Ritter P; Khelae SK; Iacopino S; Garweg C; Grazia-Bongiorni M; Neuzil P; Johansen JB; Mont L; Gonzalez E; Sagi V; Duray GZ; Clementy N; Sheldon T; Splett V; Stromberg K; Wood N; Steinwender C
    Heart Rhythm; 2018 Sep; 15(9):1363-1371. PubMed ID: 29758405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac optogenetics: the next frontier.
    Gruber A; Edri O; Gepstein L
    Europace; 2018 Dec; 20(12):1910-1918. PubMed ID: 29315402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optogenetic termination of atrial fibrillation in mice.
    Bruegmann T; Beiert T; Vogt CC; Schrickel JW; Sasse P
    Cardiovasc Res; 2018 Apr; 114(5):713-723. PubMed ID: 29293898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. All-optical control of cardiac excitation: combined high-resolution optogenetic actuation and optical mapping.
    Entcheva E; Bub G
    J Physiol; 2016 May; 594(9):2503-10. PubMed ID: 26857427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optogenetic Control of Human Induced Pluripotent Stem Cell-Derived Cardiac Tissue Models.
    Gruber A; Edri O; Glatstein S; Goldfracht I; Huber I; Arbel G; Gepstein A; Chorna S; Gepstein L
    J Am Heart Assoc; 2022 Feb; 11(4):e021615. PubMed ID: 35112880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of SCN5A in mouse heart mimics human syndrome of enhanced atrioventricular nodal conduction.
    Liu GX; Remme CA; Boukens BJ; Belardinelli L; Rajamani S
    Heart Rhythm; 2015 May; 12(5):1036-45. PubMed ID: 25623181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Towards miniaturized closed-loop optogenetic stimulation devices.
    Edward ES; Kouzani AZ; Tye SJ
    J Neural Eng; 2018 Apr; 15(2):021002. PubMed ID: 29363618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advanced Cardiac Rhythm Management by Applying Optogenetic Multi-Site Photostimulation in Murine Hearts.
    Diaz-Maue L; Steinebach J; Schwaerzle M; Luther S; Ruther P; Richter C
    J Vis Exp; 2021 Aug; (174):. PubMed ID: 34515679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel system for mapping regional electrical properties and characterizing arrhythmia in isolated intact rat atria.
    Ramlugun GS; Sands GB; Zhao J; LeGrice IJ; Smaill BH
    Am J Physiol Heart Circ Physiol; 2021 Aug; 321(2):H412-H421. PubMed ID: 34213393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.